Relapsing-Remitting Multiple Sclerosis: What is the Potential for Combination Therapy?

ISSN： 1173-8804

Source： BioDrugs, Vol.13, Iss.3, 2000-03, pp. : 149-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

By Simpson D. Noble S. Perry C.

BioDrugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David Lyseng-Williamson Katherine A.

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack Lesley J. Scott

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite

Recombinant Interferon- -1a: A Review of its Therapeutic Efficacy in Relapsing-Remitting Multiple Sclerosis

By Wagstaff A.J. Goa K.L.

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 471-494

Adis International

Access to resources Recommend Favorite

Anti-Interleukin-12 Antibody: Potential Role in Preventing Relapses of Multiple Sclerosis

By Fox R.J. Rostami A.M.

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 233-241

Adis International

Access to resources Recommend Favorite